ATE552011T1 - Kolorektal-karzinom-antigen - Google Patents

Kolorektal-karzinom-antigen

Info

Publication number
ATE552011T1
ATE552011T1 AT04790870T AT04790870T ATE552011T1 AT E552011 T1 ATE552011 T1 AT E552011T1 AT 04790870 T AT04790870 T AT 04790870T AT 04790870 T AT04790870 T AT 04790870T AT E552011 T1 ATE552011 T1 AT E552011T1
Authority
AT
Austria
Prior art keywords
colorectal carcinoma
carcinoma antigen
eliciting
coa
diagnostic
Prior art date
Application number
AT04790870T
Other languages
English (en)
Inventor
Paul Robbins
Steven Rosenberg
Cristina Maccalli
Original Assignee
Ist Superiore Sanita
Nat Inst Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Nat Inst Health filed Critical Ist Superiore Sanita
Application granted granted Critical
Publication of ATE552011T1 publication Critical patent/ATE552011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04790870T 2003-10-15 2004-10-15 Kolorektal-karzinom-antigen ATE552011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51204003P 2003-10-15 2003-10-15
PCT/EP2004/012087 WO2005039632A1 (en) 2003-10-15 2004-10-15 Colorectal cancer antigen

Publications (1)

Publication Number Publication Date
ATE552011T1 true ATE552011T1 (de) 2012-04-15

Family

ID=34520047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04790870T ATE552011T1 (de) 2003-10-15 2004-10-15 Kolorektal-karzinom-antigen

Country Status (6)

Country Link
US (1) US20090311279A1 (de)
EP (1) EP1677820B1 (de)
JP (1) JP2007519612A (de)
AT (1) ATE552011T1 (de)
CA (1) CA2542686A1 (de)
WO (1) WO2005039632A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080031900A1 (en) * 2006-06-30 2008-02-07 Baylor Research Institute Dendritic Cells Generated Using GM-CSF and Interferon Alpha and Loaded with Heat-Treated and Killed Cancer Cells
CN101669031A (zh) * 2007-02-27 2010-03-10 森托科隆股份公司 使用与细胞外标记物结合的试剂组多重检测肿瘤细胞
US20180133327A1 (en) * 2015-03-16 2018-05-17 Amal Therapeutics Sa Cell Penetrating Peptides and Complexes Comprising the Same
DK3429618T5 (da) 2016-03-16 2024-09-16 Amal Therapeutics Sa Kombination af en immuncheckpoint-modulator og et kompleks som omfatter et cellepenetrerende peptid, en last og en tlr-peptidagonist til anvendelse i medicin
DK3515476T3 (da) 2016-09-21 2024-09-02 Amal Therapeutics Sa Fusion der omfatter et cellepenetrerende peptid, en multiepitop og en trl-peptidagnost til behandlingen af cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291430B1 (en) * 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
JP2003135075A (ja) * 2001-11-05 2003-05-13 Research Association For Biotechnology 新規な全長ｃＤＮＡ
EP1519741A2 (de) * 2001-12-07 2005-04-06 Incyte Genomics, Inc. Mit zellwachstum, -differenzierung und -tod assoziierte proteine

Also Published As

Publication number Publication date
EP1677820A1 (de) 2006-07-12
JP2007519612A (ja) 2007-07-19
WO2005039632A1 (en) 2005-05-06
EP1677820B1 (de) 2012-04-04
WO2005039632B1 (en) 2005-08-18
CA2542686A1 (en) 2005-05-06
US20090311279A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
NO20026245L (no) Forbedring av antistoff-cytokinfusjonsproteinformidlede immunresponser vedkombinert behandling med immuncytokinopptakforbedrende midler
CY1111591T1 (el) Υβριδικη εκφραση πρωτεϊνων των neisseria
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
EP1572728A4 (de) Polymer-konjugate mit verringerterantigenität, herstellungsverfahren undverwendungen
AU2004205878A8 (en) Gene expression markers for breast cancer prognosis
TR200200774T2 (tr) Aşılar.
DE60329287D1 (de) Boehmitteilchen und diese enthaltende polymermaterialien
DK1617861T3 (da) Human serumalbumin-fri stabiliserede interferon flydende formuleringer
ATE552011T1 (de) Kolorektal-karzinom-antigen
WO2002075507A3 (en) Anti-bacterial vaccine compositions
EP1230932A3 (de) Verwendung von Antikörpern zur Vakzinierung gegen Krebs
ITFI20020038A1 (it) Coloranti ceramici in forma di sospensioni nanometriche
FR2831442B1 (fr) Composition cosmetique mimant le sebum, et utilisations
ITRM20020306A0 (it) Esteri in posizione 20 di camptotecine.
WO2005013904A3 (en) Sars nucleic acids, proteins, vaccines, and uses thereof
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
FR2803599B1 (fr) Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications
WO2002076384A3 (en) Therapeutic compositions that alter the immune response
WO2008009028A3 (en) Methods of determining the prognosis of an adenocarcinoma
WO2004034995A3 (en) Methods and reagents for inducing immunity
ATE355301T1 (de) Moraxella catharralis proteine
AU2003264319A1 (en) New tumor antigen vaccine and producing method and vaccine composition
DE10290185D2 (de) Tumorvakzine
DK1313850T3 (da) Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer